Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-04-26

FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the telmisartan and hydrochlorothiazide combination product, updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Hydrochlorothiazide (telmisartan and hydrochlorothiazide)

Snippet

SUPPL AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)